Loading data
GMABNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 3.72 bn USD | 3.12 bn USD | 2.39 bn USD |
| Cost of revenue | 238 m USD | 143 m USD | 33 m USD |
| Research and development expense | 1.61 bn USD | 1.41 bn USD | 1.11 bn USD |
| Selling, general and administrative expense | 626 m USD | 549 m USD | 478 m USD |
| Operating profit | 1.07 bn USD | 972 m USD | 772 m USD |
| Interest expense | 269 m USD | 291 m USD | 254 m USD |
| Profit before tax | 1.2 bn USD | 1.33 bn USD | 817 m USD |
| Income tax expense | 241 m USD | 193 m USD | 186 m USD |
| Net income (reported basis) | 963 m USD | 1.13 bn USD | 631 m USD |
| Basic earnings per share | 15.5 USD/share | 17.66 USD/share | 9.67 USD/share |
| Diluted earnings per share | 15.37 USD/share | 17.53 USD/share | 9.58 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.